| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240020 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 9 Pages |
Abstract
Ampullary cancers have a distinctly better treatment outcome than pancreatic adenocarcinomas. Higher primary tumor stage (T3/T4), an independent adverse risk factor for poorer treatment outcomes, may warrant the addition of adjuvant CRT to pancreaticoduodenectomy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sunil M.D., Vishal M.D., Douglas B. M.D., Gauri M.D., Prajnan M.D., Sumita M.D., Marc E. M.D., Nora A. M.D., Robert A. M.D., Christopher H. M.D., Peter W. M.D.,